DD144542A5 - Verfahren zur herstellung von 4-substituierten thiazoloxamsaeuren sowie ihren salzen und estern - Google Patents

Verfahren zur herstellung von 4-substituierten thiazoloxamsaeuren sowie ihren salzen und estern Download PDF

Info

Publication number
DD144542A5
DD144542A5 DD79213848A DD21384879A DD144542A5 DD 144542 A5 DD144542 A5 DD 144542A5 DD 79213848 A DD79213848 A DD 79213848A DD 21384879 A DD21384879 A DD 21384879A DD 144542 A5 DD144542 A5 DD 144542A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
thiazole
oxamic acid
hydrogen
radical
Prior art date
Application number
DD79213848A
Other languages
German (de)
English (en)
Inventor
Friedrich K Hess
Patrick B Stewart
James T Oliver
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DD144542A5 publication Critical patent/DD144542A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD79213848A 1978-06-27 1979-06-22 Verfahren zur herstellung von 4-substituierten thiazoloxamsaeuren sowie ihren salzen und estern DD144542A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782828091 DE2828091A1 (de) 1978-06-27 1978-06-27 4-substituierte thiazoloxamsaeuren sowie ihre salze und ester

Publications (1)

Publication Number Publication Date
DD144542A5 true DD144542A5 (de) 1980-10-22

Family

ID=6042852

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79213848A DD144542A5 (de) 1978-06-27 1979-06-22 Verfahren zur herstellung von 4-substituierten thiazoloxamsaeuren sowie ihren salzen und estern

Country Status (36)

Country Link
US (1) US4238496A (xx)
JP (1) JPS557290A (xx)
AT (1) AT373884B (xx)
AU (1) AU525312B2 (xx)
BE (1) BE877293A (xx)
BG (1) BG30324A3 (xx)
CA (1) CA1246071A (xx)
CH (1) CH644370A5 (xx)
CS (1) CS208114B2 (xx)
DD (1) DD144542A5 (xx)
DE (1) DE2828091A1 (xx)
DK (1) DK147940C (xx)
ES (1) ES481917A1 (xx)
FI (1) FI69456C (xx)
FR (1) FR2429787A1 (xx)
GB (1) GB2023580B (xx)
GR (1) GR69231B (xx)
HK (1) HK66285A (xx)
HU (1) HU178996B (xx)
IE (1) IE48357B1 (xx)
IL (1) IL57659A0 (xx)
IT (1) IT1120443B (xx)
LU (1) LU81424A1 (xx)
MY (1) MY8600653A (xx)
NL (1) NL7904957A (xx)
NO (1) NO151500C (xx)
NZ (1) NZ190842A (xx)
PH (1) PH17226A (xx)
PL (1) PL117333B1 (xx)
PT (1) PT69822A (xx)
RO (1) RO77553A (xx)
SE (1) SE446182B (xx)
SG (1) SG61985G (xx)
SU (1) SU791237A3 (xx)
YU (1) YU41645B (xx)
ZA (1) ZA793176B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
DE3027528A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Ueberbrueckte thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3027527A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2494272A1 (fr) * 1980-11-19 1982-05-21 Fabre Sa Pierre Derives de l'acide thiazolyl-2 oxamique substitues en position 4 par un radical thienyle ou furyle, leur preparation et leur utilisation comme medicaments
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3474817D1 (en) * 1983-09-01 1988-12-01 Boehringer Ingelheim Ltd Diazine-ethenylphenyl oxamic acids and esters and salts thereof
US4788198A (en) * 1983-09-01 1988-11-29 Boehringer Ingelheim Pharmaceuticals, Inc. Diazine-ethyenylphenyl oxamic acids and esters and salts thereof
US4681884A (en) * 1983-09-01 1987-07-21 Boehringer Ingelheim Pharmaceuticals, Inc. Diazine-ethenylphenyl oxamic acids and esters and salts thereof
IT1204959B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
IT1204960B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JPH0667836B2 (ja) * 1989-03-01 1994-08-31 東洋紡績株式会社 アミド系化合物からなる抗アレルギー剤
FR2671552B1 (fr) * 1991-01-15 1993-05-07 Pf Medicament Procede de preparation de thiazolyl-2 oxamates d'alkyle.
DE69821132T2 (de) * 1997-10-27 2004-10-21 Takeda Chemical Industries Ltd 1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1062245B (de) * 1957-10-17 1959-07-30 Ciba Geigy Verfahren zur Herstellung von 2-Amino-4-pyridyl-(2')-thiazol und seinen Salzen
FR1526074A (fr) * 1967-03-22 1968-05-24 Rech S Ind S O R I Soc D Méthoxy-phényl-amino-2-thiazoles, leurs amides et leurs procédés de préparation
BE795907A (fr) * 1972-02-25 1973-06-18 Luso Farmaco Inst 2-amino-4-arylthiazoles 5-substitues et leur preparation
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US3966965A (en) * 1973-03-23 1976-06-29 American Home Products Corporation Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions
FR2429210A1 (fr) * 1978-06-19 1980-01-18 Fabre Sa Pierre Derives de phenyl-4 thiazolyl-2 oxamates utiles dans le traitement de l'asthme

Also Published As

Publication number Publication date
CS208114B2 (en) 1981-08-31
MY8600653A (en) 1986-12-31
YU149779A (en) 1982-10-31
ZA793176B (en) 1981-03-25
GB2023580B (en) 1982-08-25
AU525312B2 (en) 1982-10-28
AU4839779A (en) 1980-01-03
DK147940C (da) 1985-09-02
FI69456B (fi) 1985-10-31
IL57659A0 (en) 1979-10-31
NZ190842A (en) 1981-01-23
US4238496A (en) 1980-12-09
FR2429787B1 (xx) 1982-12-31
ES481917A1 (es) 1980-02-16
NO151500B (no) 1985-01-07
JPS6356225B2 (xx) 1988-11-07
HU178996B (en) 1982-07-28
DE2828091C2 (xx) 1988-05-26
IE48357B1 (en) 1984-12-26
GB2023580A (en) 1980-01-03
FI69456C (fi) 1986-02-10
SG61985G (en) 1986-05-02
SE446182B (sv) 1986-08-18
FI792006A (fi) 1979-12-28
PH17226A (en) 1984-07-03
IT1120443B (it) 1986-03-26
ATA431879A (de) 1983-07-15
PT69822A (de) 1979-07-01
NO792139L (no) 1979-12-28
FR2429787A1 (fr) 1980-01-25
NL7904957A (nl) 1980-01-02
IE791200L (en) 1979-12-27
PL216608A1 (xx) 1980-03-24
JPS557290A (en) 1980-01-19
SE7905608L (sv) 1979-12-28
YU41645B (en) 1987-12-31
LU81424A1 (de) 1980-07-21
CA1246071A (en) 1988-12-06
DK147940B (da) 1985-01-14
GR69231B (xx) 1982-05-10
IT7949533A0 (it) 1979-06-25
DE2828091A1 (de) 1980-01-10
PL117333B1 (en) 1981-07-31
SU791237A3 (ru) 1980-12-23
RO77553A (ro) 1982-02-01
DK269879A (da) 1979-12-28
HK66285A (en) 1985-09-13
CH644370A5 (de) 1984-07-31
BE877293A (fr) 1979-12-27
NO151500C (no) 1985-04-24
AT373884B (de) 1984-02-27
BG30324A3 (en) 1981-05-15

Similar Documents

Publication Publication Date Title
DD144542A5 (de) Verfahren zur herstellung von 4-substituierten thiazoloxamsaeuren sowie ihren salzen und estern
CH625522A5 (xx)
EP0025192B1 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
DD295363A5 (de) Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten
DD209446A5 (de) Verfahren zur herstellung von neuen aromatischen verbindungen
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2414273B2 (de) N-Methyl-D-glucaminsalz von 2-(2'-Methyl-3'-trifluormethyl-anilin)-nicotinsäure, Verfahren zu seiner Herstellung und es enthaltende Arzneimittelzubereitung
DE2418344A1 (de) Derivate von 3-nitrocumarinen enthaltende arzneimittel, neue 3-nitrocumarine und verfahren zu ihrer herstellung
DE1545575B1 (de) N,N'-Bis-[3-(3',4',5'-trimethoxybenzoyloxy)-propyl]-homopiperazin
DE2123924B2 (xx)
EP0075140B1 (de) Tricyclische Thiazolyloxamidsäuren und Derivate, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
DE2931418A1 (de) Neue imidazochinoxaline und deren salze, verfahren zu deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden pharmazeutischen zusammensetzungen
DE2252637C3 (de) Verwendung von 1,3-Glycerindiäthern
DE2952652A1 (de) 1,2-dihydro-2-oxonikotinsaeurederivate und diese enthaltende arzneimittel
DE2929760C2 (xx)
DE1001261C2 (de) Verfahren zur Herstellung von basischen Estern endocyclisch substituierter Mandelsaeuren und ihren Salzen
EP0072960A2 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2513930A1 (de) 1-oxo-1h-6-hydroxypyrimido eckige klammer auf 1,2-a eckige klammer zu chinolin-2-carbonsaeuren und deren derivate
DE2253914A1 (de) Neue chromonderivate und verfahren zu ihrer herstellung
EP0241834A2 (de) Verwendung von 3-Carbamoyl-4-hydroxy-cumarinen zur Bekämpfung von parasitären Helminthen, neue 3-Carbamoyl-4-hydroxy-cumarine und ihre Herstellung
DE2804293A1 (de) Alpha-aryl-gamma-oxo-isovaleriansaeure-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2412388A1 (de) Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2446497A1 (de) 4-oxo-4h-pyrano- eckige klammer auf 3,2-c eckige klammer zu -chinolin-2-carbonsaeuren und ihre salze
DE2164638C3 (de) Kernsubstituierte Phenoxyäthylamine, Verfahren zu ihrer Herstellung und sie enthal tende Arzneimittel
CH647235A5 (de) 4-(2,2-dialkylindan-1-yliden)piperidin derivate, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee